EUVIMEDEUVIMED entdecken
Multizentrische Studie

Direct Acting Antivirals Before Surgical Resection of HCV Related HCC : Impact on Tumour Pathology and Outcomes

Giuseppina Brancaccio iD, Alessandro Vitale, Francesco Paolo Russo, Giuseppe Cabibbo, Salvatore Gruttadauria iD, Duilio Pagano, Giovanni Battista Levi Sandri, Valerio Giannelli, Matteo Cescon, Carlo Sposito, Daniele Nicolini, Leonardo Centonze und 21 weitere

Liver International · 2026-07 · 46 (7)

DOI: 10.1111/liv.70738 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 09.06.2026. Verfasst von Giuseppina Brancaccio und 32 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases, Department of Life Sciences, Health and Health Professions, Link Campus University, Rome, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Liver Neoplasms, Carcinoma, Hepatocellular, Hepatectomy. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The impact of direct‐acting antivirals (DAA) on the pathological characteristics and postoperative outcome of HCV‐related hepatocellular carcinoma (HCC) in patients undergoing liver resection (LR) remains uncertain. We assessed aggressive tumour pathology (composite outcome comprising vascular invasion, poor grading or satellitosis), severe postoperative complications (Clavien–Dindo grade > 2), recurrence‐free survival (RFS), and overall survival (OS) in patients with HCC treated with or without DAA before LR.

Methods

Among 651 consecutive patients with HCV‐related HCC who underwent LR in 17 Italian centres (2014–2016), we included 447 patients with concordant HCV‐RNA status: 107 DAA‐treated patients who were HCV‐RNA‐negative at resection (DAA‐pre) and 340 HCV‐RNA‐positive patients without pre‐resection DAA (No‐DAA). DAA treatment was modelled as a time‐varying covariate in Cox regression to avoid immortal time bias.

Results

The DAA‐pre group was younger (median age 66 vs. 70 years) and had smaller tumours (25 vs. 35 mm). Aggressive tumour pathology did not differ between groups (58.9% vs. 64.4%, p = 0.358). In multivariable analysis, DAA was not associated with aggressive pathology (OR 1.01, 95% CI 0.63–1.63, p = 0.961). Severe complications tended to be less common in DAA‐pre patients (3.9% vs. 11.0%, p = 0.073) while hospital stay was shorter (6 vs. 7 days, p = 0.018). Time‐varying multivariable Cox regression showed no significant association between DAA treatment and RFS (HR 0.87, 95% CI 0.66–1.16, p = 0.351), but a strong association with improved OS (HR 0.49, 95% CI 0.35–0.68, p < 0.001).

Conclusions

Pre‐resection DAA treatment did not affect tumour aggressiveness and tended to be associated with fewer severe early complications. Time‐varying analyses suggested an additional survival benefit of DAA treatment, although in a single‐arm observational cohort the relative contribution of pre‐ and post‐resection DAA cannot be disentangled with certainty. These findings support viral eradication as early as possible, including before surgical resection of HCV‐related HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsLiver NeoplasmsCarcinoma, HepatocellularHepatectomyHepatitis C, ChronicHumansFemaleMaleAgedMiddle AgedItalyTreatment OutcomeProportional Hazards ModelsHepacivirusRetrospective StudiesPostoperative Complications

Stichwörter der Autor:innen

direct‐acting antiviralshepatitis Chepatocellular carcinomatumour pathology

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Infectious Diseases, Department of Life Sciences, Health and Health Professions, Link Campus University, Rome, Italy.
  • Department of Surgical, Oncological, and Gastroenterological Sciences, Padua University, Padua, Italy.
  • Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Italy.
  • Department Abdominal Center, IRCCS-ISMETT-UPMCI, Palermo, Italy.
  • University of Catania, Catania, Italy.
  • Department of General Surgery and Transplantation Unit, San Camillo Forlanini Hospital, Rome, Italy.

ORCID-Profile: Giuseppina Brancaccio, Salvatore Gruttadauria, Stefano Di Sandro, Davide Ghinolfi, Maria Rendina, Francesca Romana Ponziani

Förderung

  • Gilead Sciences

Zitieren

APA

Brancaccio, G., Vitale, A., Russo, F. P., Cabibbo, G., Gruttadauria, S., Pagano, D., Sandri, G. B. L., Giannelli, V., Cescon, M., Sposito, C., Nicolini, D., Centonze, L., Di Sandro, S., Ghinolfi, D., Di Costanzo, G., Tortora, R., Viganò, L., Romano, F., Garancini, M., …, & Cillo, U. (2026). Direct Acting Antivirals Before Surgical Resection of HCV Related HCC : Impact on Tumour Pathology and Outcomes. Liver International, 46(7). https://doi.org/10.1111/liv.70738

Vancouver

Brancaccio G, Vitale A, Russo FP, Cabibbo G, Gruttadauria S, Pagano D, et al. Direct Acting Antivirals Before Surgical Resection of HCV Related HCC : Impact on Tumour Pathology and Outcomes. Liver International. 2026;46(7). doi:10.1111/liv.70738

BibTeX
@article{Brancaccio2026,
  author = {Brancaccio, Giuseppina and Vitale, Alessandro and Russo, Francesco Paolo and Cabibbo, Giuseppe and Gruttadauria, Salvatore and Pagano, Duilio and Sandri, Giovanni Battista Levi and Giannelli, Valerio and Cescon, Matteo and Sposito, Carlo and Nicolini, Daniele and Centonze, Leonardo and Di Sandro, Stefano and Ghinolfi, Davide and Di Costanzo, Giovanni and Tortora, Raffaella and Viganò, Luca and Romano, Fabrizio and Garancini, Mattia and Rendina, Maria and Ponziani, Francesca Romana and Giuliante, Felice and Manzia, Tommaso and Baccarani, Umberto and Pravisani, Riccardo and Melandro, Fabio and Lai, Quirino and Iavarone, Massimo A and Morisco, Filomena and D'Amico, Francesco and Giannini, Edoardo and Gaeta, Giovanni Battista and Cillo, Umberto},
  title = {Direct Acting Antivirals Before Surgical Resection of HCV Related HCC : Impact on Tumour Pathology and Outcomes},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {7},
  doi = {10.1111/liv.70738}
}
Kostenlos starten →